ALKBH5 and glioblastoma: Zhang et al. [59] showed that ALKBH5 is upregulated in GSCs and enhances cell self-renewal, proliferation, and tumorigenicity by increasing the FOXM1 expression level, which is a key target gene in patients with GBM.